https://www.selleckchem.com/pr....oducts/phosphoramido
023), site of treatment (p = 0.001), and weight loss during RT (p = 0.044). Every 1 kg lost increased the risk of death by 25% compared with patients who maintained or gained weight during RT. Changes in phase angle and standardized phase angle after RT were not associated with increased mortality risk. Weight loss during RT, site of treatment, and age are associated with a higher risk of death in cancer patients after the 10-year follow-up. Weight loss during RT, site of treatment, and age are associated with a hig
Like
Comment
Share
